PCLOF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
5.94M
RGEDF
Price
$29.25
Change
+$2.08 (+7.66%)
Updated
Sep 4 closing price
Capitalization
5.56B
Interact to see
Advertisement

PCLOF vs RGEDF

Header iconPCLOF vs RGEDF Comparison
Open Charts PCLOF vs RGEDFBanner chart's image
PHARMACIELO
Price$0.04
Change-$0.00 (-0.00%)
Volume$10K
Capitalization5.94M
Gedeon Richter
Price$29.25
Change+$2.08 (+7.66%)
Volume$3
Capitalization5.56B
PCLOF vs RGEDF Comparison Chart in %
Loading...
PCLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCLOF vs. RGEDF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCLOF is a StrongBuy and RGEDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (PCLOF: $0.04 vs. RGEDF: $29.25)
Brand notoriety: PCLOF and RGEDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PCLOF: 20% vs. RGEDF: 100%
Market capitalization -- PCLOF: $5.94M vs. RGEDF: $5.56B
PCLOF [@Pharmaceuticals: Generic] is valued at $5.94M. RGEDF’s [@Pharmaceuticals: Generic] market capitalization is $5.56B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCLOF’s FA Score shows that 0 FA rating(s) are green whileRGEDF’s FA Score has 1 green FA rating(s).

  • PCLOF’s FA Score: 0 green, 5 red.
  • RGEDF’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEDF is a better buy in the long-term than PCLOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCLOF’s TA Score shows that 4 TA indicator(s) are bullish while RGEDF’s TA Score has 2 bullish TA indicator(s).

  • PCLOF’s TA Score: 4 bullish, 3 bearish.
  • RGEDF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, PCLOF is a better buy in the short-term than RGEDF.

Price Growth

PCLOF (@Pharmaceuticals: Generic) experienced а +89.81% price change this week, while RGEDF (@Pharmaceuticals: Generic) price change was +7.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEDF($5.56B) has a higher market cap than PCLOF($5.94M). RGEDF YTD gains are higher at: 7.641 vs. PCLOF (-21.372). RGEDF has higher annual earnings (EBITDA): 335B vs. PCLOF (-4.6M). RGEDF has more cash in the bank: 150B vs. PCLOF (148K). PCLOF has less debt than RGEDF: PCLOF (20.5M) vs RGEDF (21.6B). RGEDF has higher revenues than PCLOF: RGEDF (903B) vs PCLOF (3.48M).
PCLOFRGEDFPCLOF / RGEDF
Capitalization5.94M5.56B0%
EBITDA-4.6M335B-0%
Gain YTD-21.3727.641-280%
P/E RatioN/A8.19-
Revenue3.48M903B0%
Total Cash148K150B0%
Total Debt20.5M21.6B0%
FUNDAMENTALS RATINGS
PCLOF vs RGEDF: Fundamental Ratings
PCLOF
RGEDF
OUTLOOK RATING
1..100
5934
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9947
PRICE GROWTH RATING
1..100
5150
P/E GROWTH RATING
1..100
10042
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGEDF's Valuation (2) in the null industry is somewhat better than the same rating for PCLOF (60). This means that RGEDF’s stock grew somewhat faster than PCLOF’s over the last 12 months.

RGEDF's Profit vs Risk Rating (68) in the null industry is in the same range as PCLOF (100). This means that RGEDF’s stock grew similarly to PCLOF’s over the last 12 months.

RGEDF's SMR Rating (47) in the null industry is somewhat better than the same rating for PCLOF (99). This means that RGEDF’s stock grew somewhat faster than PCLOF’s over the last 12 months.

RGEDF's Price Growth Rating (50) in the null industry is in the same range as PCLOF (51). This means that RGEDF’s stock grew similarly to PCLOF’s over the last 12 months.

RGEDF's P/E Growth Rating (42) in the null industry is somewhat better than the same rating for PCLOF (100). This means that RGEDF’s stock grew somewhat faster than PCLOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PCLOFRGEDF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
29%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
35%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
24%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
21%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PCLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RETO1.840.24
+14.70%
ReTo Eco-Solutions Inc
SIFY11.170.94
+9.14%
Sify Technologies Ltd
CLYM2.390.06
+2.58%
Climb Bio Inc
NTR56.43-0.55
-0.97%
Nutrien Ltd
CXT61.10-0.62
-1.00%
Crane NXT Co

PCLOF and

Correlation & Price change

A.I.dvisor tells us that PCLOF and OWPC have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCLOF and OWPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCLOF
1D Price
Change %
PCLOF100%
+5.13%
OWPC - PCLOF
8%
Poorly correlated
-0.25%
PHCUF - PCLOF
7%
Poorly correlated
N/A
RGEDF - PCLOF
5%
Poorly correlated
N/A
OVATF - PCLOF
4%
Poorly correlated
N/A
ROMJF - PCLOF
3%
Poorly correlated
-4.79%
More

RGEDF and

Correlation & Price change

A.I.dvisor tells us that RGEDF and YCBD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGEDF and YCBD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEDF
1D Price
Change %
RGEDF100%
N/A
YCBD - RGEDF
28%
Poorly correlated
+1.44%
OMID - RGEDF
6%
Poorly correlated
N/A
OVATF - RGEDF
6%
Poorly correlated
N/A
PCLOF - RGEDF
5%
Poorly correlated
+5.13%
OWPC - RGEDF
4%
Poorly correlated
-0.25%
More